PROGRESSION-FREE SURVIVAL IS A POOR SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN THE FIRST LINE EGFR-TKI TREATMENT IN ADVANCED NON-SMALL-CELL LUNG CANCER WITH EGFR MUTATION

被引：0
|
作者：
Liao, Ri-Qiang [1 ]
Yang, Xue-Ning [2 ]
Yan, Hong-Hong [2 ]
Zhou, Qing [2 ]
Wu, Yi-Long [3 ]
Zhong, Wen Zhao [3 ]
机构：
[1] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Div Pulm Oncol, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Gen Hosp, Div Pulm Oncol, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Surrogate; PFS; EGFR mutation; OS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.11-044
引用
收藏
页码：S615 / S615
页数：1
相关论文
共 50 条
  • [1] The depth of response was associated with the progression-free survival in advanced non-small cell lung cancer patients treated with EGFR-TKI
    Liu, Yutao
    Zhang, Kai
    Li, Chengcheng
    Hu, Xingsheng
    Jiang, Jun
    Hao, Xuezhi
    Wang, Yan
    Li, Junling
    Xing, Puyuan
    Yang, Sheng
    Zhang, Xin
    Wang, Guoqiang
    Cai, Shangli
    Shi, Yuankai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI
    Liu, Yu-Tao
    Zhang, Kai
    Li, Cheng-Cheng
    Hu, Xing-Sheng
    Jiang, Jun
    Hao, Xue-Zhi
    Wang, Yan
    Li, Jun-Ling
    Xing, Pu-Yuan
    Yang, Sheng
    Zhang, Xin
    Wang, Guo-Qiang
    Cai, Shang-Li
    Shi, Yuan-Kai
    [J]. JOURNAL OF CANCER, 2019, 10 (21): : 5108 - 5113
  • [3] Clinical benefit of second EGFR-TKI retreatment on overall survival in patients with advanced non-small-cell lung cancer harboring EGFR-mutation positive after failure of the initial EGFR-TKI treatment: A retrospective analysis.
    Nakashima, Masanao
    Hirose, Takashi
    Oki, Yasunari
    Murata, Yasunori
    Sugiyama, Tomohide
    Ishida, Hiroo
    Okuda, Kentaro
    Yamaoka, Toshimitsu
    Ohmori, Tohru
    Ohnishi, Tsukasa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer
    Nan, Xueli
    Xie, Chao
    Yu, Xueyan
    Liu, Jie
    [J]. ONCOTARGET, 2017, 8 (43) : 75712 - 75726
  • [5] TKI as First Line Treatment in Advanced Non-Small-Cell Lung Cancer with EGFR Mutations
    Guerreiro, Ines
    Silva, Ana Vitor
    Rodrigues, Ana
    Oliveira, Cristina
    Pousa, Ines
    Oliveira, Julio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1244 - S1245
  • [6] Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients
    Wu, Ting-Hui
    Hsiue, Emily Han-Chung
    Lee, Jih-Hsiang
    Lin, Chia-Chi
    Liao, Wei-Yu
    Ho, Chao-Chi
    Shih, Jin-Yuan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    [J]. CLINICAL LUNG CANCER, 2018, 19 (03) : E361 - E372
  • [7] Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Kogure, Yoshihito
    Saka, Hideo
    Oki, Masahide
    Saito, Toshiki I.
    Ahmed, Shimaa Nour Moursi
    Kitagawa, Chiyoe
    Imaizumi, Kazuyoshi
    [J]. PLOS ONE, 2015, 10 (08):
  • [8] Time trends in overall survival (OS) and progression-free survival (PFS) in the first-line treatment of advanced non-small-cell lung cancer (NSCLC).
    Rutkowski, Jacek
    Saad, Everardo D.
    Buyse, Marc E.
    Jassem, Jacek
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
  • [10] Long Progression Free Survival and Overall Survival in Advanced NSCLC Patients with EGFR Mutation and Complete Response with TKI Treatment
    Macedo-Perez, O.
    Lyra-Gonzalez, I.
    Marroquin-Flores, D.
    Cruz-Rico, G.
    Ramirez-Tirado, L.
    Valdez-Rojas, L.
    Tabares-Nanez, A.
    Gonzales-Nogales, J.
    Arrieta, O.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2087 - S2087
12345